Tag: NEJM
New NEJM Trial Shows Romiplostim Reduces Chemotherapy-Induced Thrombocytopenia Risk
A randomized controlled trial in NEJM shows romiplostim significantly reduces chemotherapy-induced thrombocytopenia compared to placebo. The findings could transform cancer…
New Pancreatic Cancer Drug Daraxonrasib Shows Promise in Phase 2 Trial
A phase 2 trial published in NEJM shows promise for daraxonrasib, a novel targeted therapy for previously treated metastatic pancreatic…
Multiple Myeloma Treatment Paradigm Shift: New Guidelines Redefine Early Relapse
New England Journal of Medicine editorial calls for fundamental changes to multiple myeloma early relapse definitions, arguing biological markers should…
Heart patch therapy shows promise for repairing damaged cardiac tissue
New editorial in NEJM explores cardiac patch therapy as a revolutionary approach to heart repair. These innovative treatments could restore…
Submit Your Paper to GMJ
No APC until January 2027.